These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1277711)

  • 21. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
    Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variations in prothrombin time and international normalized ratio over 24 hours in warfarin-treated patients.
    Bleske BE; Welage LS; Warren EW; Brown MB; Shea MJ
    Pharmacotherapy; 1995; 15(6):709-12. PubMed ID: 8602377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats.
    Yacobi A; Lai CM; Levy G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):80-4. PubMed ID: 6491977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between diet and anticoagulant response to warfarin: a factor analysis.
    Custódio das Dôres SM; Booth SL; Martini LA; de Carvalho Gouvêa VH; Padovani CR; de Abreu Maffei FH; Campana AO; Rupp de Paiva SA
    Eur J Nutr; 2007 Apr; 46(3):147-54. PubMed ID: 17356795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.
    Palareti G; Legnani C
    Clin Pharmacokinet; 1996 Apr; 30(4):300-13. PubMed ID: 8983860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction.
    Bjornsson TD; Meffin PJ; Swezey S; Blaschke TF
    J Pharmacol Exp Ther; 1979 Sep; 210(3):316-21. PubMed ID: 480183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipyrine and warfarin disposition in a patient with idiopathic hypoalbuminemia.
    Piroli RJ; Passananti GT; Shively CA; Vesell ES
    Clin Pharmacol Ther; 1981 Dec; 30(6):810-6. PubMed ID: 7307430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salivary excretion of warfarin in rabbits: relationship between pharmacological effect and salivary pharmacokinetics of warfarin in rabbits.
    Sakai K; Nishiura A; Fujihara Y; Kutsuna T; Nishino T
    J Pharmacobiodyn; 1983 Dec; 6(12):991-9. PubMed ID: 6674482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in plasma warfarin levels and variations in steady-state prothrombin times.
    White RH; Zhou H; Romano P; Mungall D
    Clin Pharmacol Ther; 1995 Nov; 58(5):588-93. PubMed ID: 7586953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of influenza vaccine on warfarin anticoagulation.
    Kramer P; Tsuru M; Cook CE; McClain CJ; Holtzman JL
    Clin Pharmacol Ther; 1984 Mar; 35(3):416-8. PubMed ID: 6697649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between diflunisal and warfarin.
    Serlin MJ; Mossman S; Sibeon RG; Tempero KF; Breckenridge AM
    Clin Pharmacol Ther; 1980 Oct; 28(4):493-8. PubMed ID: 7408409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and metronidazole in rats.
    Yacobi A; Lai CM; Levy G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):72-9. PubMed ID: 6491976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocyte tissue factor activity in anticoagulant-treated patients.
    Zacharski LR; Beck JR
    Thromb Res; 1983 Jan; 29(2):207-13. PubMed ID: 6845276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients.
    Miao L; Yang J; Huang C; Shen Z
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1135-41. PubMed ID: 17899045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacokinetics of coumarin anticoagulants. XLIX: Nonlinear tissue distribution of S-warfarin in rats.
    Cheung WK; Levy G
    J Pharm Sci; 1989 Jul; 78(7):541-6. PubMed ID: 2778653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Warfarin metabolites: the anticoagulant activity and pharmacology of warfarin alcohols.
    Lewis RJ; Trager WF; Robinson AJ; Chan KK
    J Lab Clin Med; 1973 Jun; 81(6):925-31. PubMed ID: 4710371
    [No Abstract]   [Full Text] [Related]  

  • 39. Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time.
    Nilsson CU; Strandberg K; Reinstrup P
    Scand J Clin Lab Invest; 2018 Sep; 78(5):358-364. PubMed ID: 29792060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial and ethnic differences in warfarin response.
    El Rouby S; Mestres CA; LaDuca FM; Zucker ML
    J Heart Valve Dis; 2004 Jan; 13(1):15-21. PubMed ID: 14765833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.